These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 19127428)

  • 21. Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.
    Chérel M; Campion L; Bézieau S; Campone M; Charrier J; Gaschet J; Ricolleau G; Gouraud W; Charbonnel C; Jézéquel P
    Cytokine; 2009 Sep; 47(3):214-23. PubMed ID: 19640729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer: beyond the cutting edge.
    Higa GM
    Expert Opin Pharmacother; 2009 Oct; 10(15):2479-98. PubMed ID: 19761355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?
    Tacca O; LeHeurteur M; Durando X; Mouret-Reynier MA; Abrial C; Thivat E; Bayet-Robert M; Penault-Llorca F; Chollet P
    Cancer Invest; 2009 Jan; 27(1):81-5. PubMed ID: 19191099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXP3 germline polymorphisms are not associated with risk of breast cancer.
    Raskin L; Rennert G; Gruber SB
    Cancer Genet Cytogenet; 2009 Apr; 190(1):40-2. PubMed ID: 19264232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Natural history of breast cancer. Implication for diagnosis and treatment].
    Tubiana M
    Bull Mem Acad R Med Belg; 2005; 160(7-9):367-84. PubMed ID: 16502973
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.
    Kissane D; Li Y
    Cancer; 2008 Jan; 112(2):443-4; author reply 444. PubMed ID: 18058897
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment-experienced breast cancer: new pathways for improving survival. Introduction.
    Waddell JA
    Am J Health Syst Pharm; 2008 May; 65(10 Suppl 3):S2-3. PubMed ID: 18463329
    [No Abstract]   [Full Text] [Related]  

  • 28. Dodging a dogma: is treating beyond progression beneficial?
    Naing A; Kurzrock R
    Cancer Chemother Pharmacol; 2013 May; 71(5):1385-6. PubMed ID: 23443308
    [No Abstract]   [Full Text] [Related]  

  • 29. Genomic sequencing of treatment-resistant metastatic breast cancer reveals key alterations.
    Printz C
    Cancer; 2017 May; 123(6):904. PubMed ID: 28263388
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychotherapy does not promote survival (Kissane et al., 2007): now what?
    Coyne JC; Hanisch LJ; Palmer SC
    Psychooncology; 2007 Nov; 16(11):1050-2. PubMed ID: 17937383
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibromatosis of the breast after mammary prosthesis implantation.
    Jamshed S; Farhan MI; Marshall MB; Nahabedian MY; Liu MC
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):687-94. PubMed ID: 18827791
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prospect of uses of single nucleotide polymorphism in the neoplasm research ].
    Lin DX; Sun T
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):257-9. PubMed ID: 15996313
    [No Abstract]   [Full Text] [Related]  

  • 33. Bibliography. Current world literature. Breast.
    Curr Opin Oncol; 2007 Nov; 19(6):673-84. PubMed ID: 17906470
    [No Abstract]   [Full Text] [Related]  

  • 34. Review: aggressive fibromatosis and breast implant.
    Khanfir K; Zouhair A
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):693-4. PubMed ID: 18827792
    [No Abstract]   [Full Text] [Related]  

  • 35. WHY DOCTORS ARE RETHINKING BREAST-CANCER TREATMENT.
    O'Connor S
    Time; 2015 Oct; 186(14):30-6. PubMed ID: 26642514
    [No Abstract]   [Full Text] [Related]  

  • 36. [New understanding of breast cancer].
    Vera-Román JM
    Med Clin (Barc); 2010 Apr; 134(12):542-3. PubMed ID: 19592047
    [No Abstract]   [Full Text] [Related]  

  • 37. Towards a renaissance of subgross breast morphology.
    Tot T
    Eur J Cancer; 2010 Jul; 46(11):1946-8. PubMed ID: 20413302
    [No Abstract]   [Full Text] [Related]  

  • 38. The media and cancer survival.
    Goodare H
    J R Soc Med; 2007 Oct; 100(10):483-4. PubMed ID: 17911134
    [No Abstract]   [Full Text] [Related]  

  • 39. CCR focus: breast cancer.
    Bates SE
    Clin Cancer Res; 2008 Dec; 14(24):7987. PubMed ID: 19088014
    [No Abstract]   [Full Text] [Related]  

  • 40. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.
    Seibold P; Schmezer P; Behrens S; Michailidou K; Bolla MK; Wang Q; Flesch-Janys D; Nevanlinna H; Fagerholm R; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Lambrechts D; Wildiers H; Kristensen V; Alnæs GG; Nord S; Borresen-Dale AL; Hooning MJ; Hollestelle A; Jager A; Seynaeve C; Li J; Liu J; Humphreys K; Dunning AM; Rhenius V; Shah M; Kabisch M; Torres D; Ulmer HU; Hamann U; Schildkraut JM; Purrington KS; Couch FJ; Hall P; Pharoah P; Easton DF; Schmidt MK; Chang-Claude J; Popanda O
    BMC Cancer; 2015 Dec; 15():978. PubMed ID: 26674097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.